Peptide profile · Hormone Support
Leuprolide
A powerful GnRH agonist that helps manage hormone-sensitive conditions by controlling hormone production.
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Typical dose
1 mg
Half-life
Approximately 2-6 hours (varies by route of administration)
Bioavailability
~95% (subcutaneous injection)
Molecular weight
1209.4 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C59H84N16O12
Primary benefits
Effectively reduces testosterone in men with prostate cancer
Relieves severe endometriosis pain and symptoms
Reversible hormone suppression with minimal long-term effects
TAP Pharmaceuticals (Abbott Laboratories & Takeda joint venture)
Amino acid sequence
pyroGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt02 · Dosing
How much do I take?
1 mg · once daily
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Best time to take
Administer Leuprolide at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Leuprolide injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Leuprolide should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
＋ Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
－ Decrease if
- −Side effects are bothersome or impacting daily life despite management strategies
- −You experience any signs of an adverse reaction
- −Lab results indicate the need for dose reduction
- −Your healthcare provider recommends a lower dose based on your response
✓ Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for managing advanced or metastatic prostate cancer & controlling severe endometriosis pain
Best for
Managing advanced or metastatic prostate cancer
Leuprolide is particularly well-suited for individuals focused on managing advanced or metastatic prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Controlling severe endometriosis pain
Leuprolide is particularly well-suited for individuals focused on controlling severe endometriosis pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Treating symptomatic uterine fibroids
Leuprolide is particularly well-suited for individuals focused on treating symptomatic uterine fibroids. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Delaying early puberty in children
Leuprolide is particularly well-suited for individuals focused on delaying early puberty in children. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Leuprolide with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Subcutaneous injection (daily) · Intramuscular injection (monthly depot)
Reconstitution — what you need
Example
Add the recommended volume of bacteriostatic water to the Leuprolide vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of Leuprolide is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Technique
- 01Wash your hands thoroughly with soap and water before handling supplies
- 02Clean the injection site with an alcohol swab and let it air dry completely
- 03Pinch a fold of skin at the chosen injection site
- 04Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 05Inject the medication slowly and steadily over 5-10 seconds
- 06Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 07Rotate injection sites to prevent tissue irritation or lipodystrophy
- 08Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage · before reconstitution
Store Leuprolide in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Storage · after reconstitution
Once reconstituted, Leuprolide should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
15 common side effects · 1 serious
Leuprolide (Lupron) is an FDA-approved GnRH agonist with 35+ years of clinical safety data involving millions of patients in oncology and endocrinology. The critical safety issue is the initial 5-7 day flare effect—temporary surge in FSH/LH causing symptom worsening before hormone suppression begins—particularly dangerous for prostate cancer patients (flare can cause urinary obstruction or spinal cord compression). Bone density loss is a dose-dependent long-term risk in both men and women requiring monitoring. Injection site reactions, hot flushes, and initial hypogonadal symptoms are expected and typically transient.
Leuprolide safety is well-established through FDA registration trials, extensive post-marketing surveillance, and hundreds of published clinical studies spanning endometriosis, prostate cancer, precocious puberty, and breast cancer indications. Long-term safety data from 10+ years of continuous therapy shows predictable hypogonadal effects with manageable metabolic consequences when monitored appropriately. Black box warnings exist for flare risk in certain prostate cancer scenarios and bone loss risk in extended use.
Common side effects · experienced by some users
Stop and seek help if
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Leuprolide
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Leuprolide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- ✓Anti-androgens (like bicalutamide) for prostate cancer — May be used together under medical guidance.
- ✓NSAIDs (like naproxen) for endometriosis pain — May be used together under medical guidance.
- ✓Bone-protecting agents (bisphosphonates) for long-term use — May be used together under medical guidance.
With medications
- !Other GnRH agonists (would cause overdosing) — Use with caution—discuss with your healthcare provider.
- !Certain medications that prolong QT interval — Use with caution—discuss with your healthcare provider.
- !Avoid if taking medications that significantly interact with testosterone suppression — Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins — Generally safe to take alongside Leuprolide. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs initial_response
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Leuprolide works by pretending to be your brain's natural GnRH hormone, but in a way that confuses your pituitary gland. For the first week, it actually stimulates hormone production, but then your body gets exhausted and shuts down the whole system. This stops testosterone in men and estrogen in women—exactly what you need for hormone-sensitive conditions like prostate cancer and endometriosis. Think of it as a switch that flips on briefly, then locks in the off position.
Leuprolide is a synthetic nonapeptide (9-amino acid sequence: pyroGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt) that acts as a potent GnRH receptor agonist. Upon subcutaneous or intramuscular administration, leuprolide binds to GnRH receptors in the anterior pituitary with high affinity. Initial agonistic activity causes rapid release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which increases testosterone production initially—this is termed 'flare.' However, continuous exposure to leuprolide causes receptor desensitization and downregulation within 7-14 days, resulting in profound suppression of gonadotropin secretion. This eliminates the LH stimulus for Leydig cell testosterone production (in males) or the FSH/LH stimulus for ovarian estrogen production (in females). Testosterone and estrogen levels typically drop 90-95% within 2-4 weeks. The sustained suppression continues as long as the medication is administered. Leuprolide's half-life is 2-3 hours for daily formulations, but depot formulations with fatty acid conjugation have extended half-lives of 2-5 weeks, enabling monthly to quarterly dosing through slow-release mechanisms.
What to expect
initial_response
What you might notice
- •May experience tumor flare (temporary worsening) if used for cancer;
- •hot flashes and decreased libido begin
What's normal
- •Full integration of Leuprolide into physiological systems is established
- •Long-term Leuprolide response remains personalized to your physiology
- •Leuprolide tolerance is well-maintained with consistent dosing
What's next
- →Maintain your established Leuprolide protocol for sustained benefits
- →Continue periodic monitoring to confirm Leuprolide efficacy
- →Review comprehensive Leuprolide response with your provider
peak_effect
What you might notice
- •Full testosterone suppression achieved;
- •endometriosis pain relief becomes noticeable;
- •tumor flare typically resolves
What's normal
- •Leuprolide has achieved stable, long-term homeostatic integration
- •Sustained efficacy of Leuprolide remains consistent
- •Chronic Leuprolide effects remain stable and predictable
What's next
- →Maintain your established Leuprolide protocol for sustained benefits
- →Continue periodic monitoring to confirm Leuprolide efficacy
- →Review comprehensive Leuprolide response with your provider
long_term
What you might notice
- •Sustained hormone suppression;
- •continued symptom relief;
- •bone density monitoring becomes important;
- •most side effects stabilize
What's normal
- •Full therapeutic effects of Leuprolide are well-characterized at this point
- •Maintenance of Leuprolide's therapeutic effects is typical
- •Tolerance patterns with Leuprolide are generally stable over months
What's next
- →Comprehensive assessment of Leuprolide efficacy should be conducted
- →Discuss long-term continuation, cycling, or protocol modifications
- →Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working · Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Leuprolide over time
- ✓Reduction in symptom frequency or severity
Signs it's working · General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key research
07 · Questions
Frequently asked
Is leuprolide a steroid?+
No, leuprolide is not a steroid. It's a peptide hormone that works on your hormone system to reduce testosterone and estrogen production. It's similar to a natural brain hormone called GnRH.
Can I get pregnant while taking leuprolide?+
No. Leuprolide significantly reduces fertility and is dangerous if you become pregnant. Women should use effective birth control during treatment. Some fertility may return after stopping, but this needs to be discussed with your doctor.
How long do I need to take leuprolide?+
That depends on your condition. For prostate cancer, it's usually long-term or continuous. For endometriosis or fibroids, treatment typically lasts 3-12 months. Your doctor will determine the right duration for you.
What's the difference between daily and depot leuprolide?+
Daily leuprolide is a shot you give yourself every day. Depot forms are longer-lasting injections given monthly, quarterly, or even yearly by a doctor. Depot is more convenient but can't be adjusted as quickly. Most people prefer depot forms.
Why do men get hot flashes from leuprolide?+
When testosterone drops suddenly, your body's temperature regulation gets confused. This is your brain responding to the hormonal change. Hot flashes usually improve over time or can be managed with medication if needed.
08 · Further reading
History & related research
History · since 1985
The first GnRH drug that gave hope to cancer patients in 1985
Leuprolide is a man-made hormone that stops the body from making certain sex hormones. Doctors use it to treat prostate cancer, endometriosis, uterine fibroids, early puberty, and to help with fertility treatments.
Read the full history of Leuprolide